QualityStocksNewsBreaks Archives - Page 704 of 1390

WednesdayMar 17, 2021 11:23 am

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Mid-Month Update Indicates Impressive Growth

Friendable (OTC: FDBL), a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications, is seeing a significant increase in artists enrolling in its exclusive Fan Pass program, which is a live-streaming platform. The company also notes an impressive uptick in social media activity on the platform as well. Ten artists have joined the Fan Pass platform so far this month, which beats February numbers — and the month is only halfway over. In addition, the company noted that social media indicators show Fan Pass’ Facebook reach is up 96%, post engagements are…

WednesdayMar 17, 2021 10:51 am

QualityStocksNewsBreaks – Augusta Gold Corp. (CSE: G) (OTCQB: AUGG) (FSE: 11B) Secures Conditional Approval for TSX Listing

Augusta Gold (CSE: G) (OTCQB: AUGG) (FSE: 11B) today announced its receipt of conditional approval to list its common shares on the Toronto Stock Exchange (the "TSX"). Concurrent with the TSX listing, Augusta Gold’s common shares will be de-listed from the Canadian Securities Exchange. Augusta Gold's trading symbol will remain "G" on the TSX. Final approval of the listing is subject to Augusta Gold meeting certain customary conditions required by the TSX. The company will issue an update upon confirmation on the effective date for commencement of trading of Augusta Gold common shares on the TSX. "We are very pleased…

WednesdayMar 17, 2021 10:33 am

QualityStocksNewsBreaks – WELL Health Technologies Corp. (TSX: WELL) Releases Management Update, Announces Seed Investment

WELL Health Technologies (TSX: WELL), a company focused on consolidating and modernizing clinical and digital assets within the healthcare sector, has made to new appointment to its leadership team. The company named Atoussa Mahmoudpour as its chief legal officer and Ammar Shah as its vice president of mergers and acquisitions (“M&A”). Mahmoudpour has been serving as WELL’s vice president of legal affairs and compliance since September 2020; before coming to WELL, she held senior positions at several leading international firms, including Eversheds Sutherland LLP. Shah also joined the WELL team last September as director of M&A; his prior experience included serving as…

WednesdayMar 17, 2021 10:22 am

QualityStocksNewsBreaks – Knightscope Inc. Announces Another Crime-Fighting Win

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), today provided an update on another crime-fighting win to add to its long list of successes (see www.Knightscope.com/Crime for others). An article published by the Las Vegas Review-Journal discusses the Knightscope MIN31KS, the human-sized autonomous robot that patrols a Las Vegas apartment complex, offering a wide variety of security measures. These include four-camera video recording, facial recognition, license plate reading, verbal warnings, a telephone-like connection with human security officers, as well as a presence that helps deter improper activity. “It’s been very useful in several ways,”…

WednesdayMar 17, 2021 9:43 am

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces Subsidiary Has Ordered First Shipment of Functional Mushrooms

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) subsidiary Pure Mushrooms Corp. has placed its first order for functional mushrooms from a British Columbia co-packer. Pure Mushrooms will use the mushrooms to produce three products, which will be offered through the company’s online e-commerce store. Previously Pure Mushrooms had developed three premium formulations based on reishi, maitake and lion’s mane mushrooms. These formulations, which are delivered in convenient vegan capsules, will be the foundation of the upcoming new products. Rreishi and maitake formulations should go on sale in April, with the lion’s mane release slated for June. The announcement…

WednesdayMar 17, 2021 9:33 am

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Enters Strategic Collaboration with JelikaLite

Brain Scientific (OTCQB: BRSF), a neurology focused medical device and software company, recently announced a collaboration with JelikaLite, a company developing Cognilum(TM), a non-invasive wearable photobiomodulation device that is being developed to increase the well-being of children living with autism, through a clinical trial. In the trial, “Transcranial Photobiomodulation for Reducing Autism Symptoms in Children,” brain treatments for children diagnosed with autism would be delivered through Cognilum, while Brain Scientific’s NeuroEEG, a wireless EEG device, will monitor brain activity. The trial is designed to provide researchers and clinicians an opportunity to potentially uncover new treatment options for reducing the symptoms…

TuesdayMar 16, 2021 3:22 pm

QualityStocksNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Announces Closing of Castillo Assets Acquisition

Green Hygienics Holdings (OTCQB: GRYN) today announced that it has closed the acquisition of certain assets of Castillo Seed LLC. (“Castillo”), a pioneering hemp seed company with an extensive library of proven genetics backed by years of research and development efforts. According to the update, the assets include seed inventories, thousands of stock plants, an established genetics portfolio, and greenhouse and seed production equipment. “We saw an opportunity to fast-track our genetics program by procuring a developed genetics portfolio, which will not only save 3-5 years of R&D work but also allow the company to propagate proprietary USDA Certified Organic…

TuesdayMar 16, 2021 2:42 pm

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Releases Q1 Revenue, Gross Profit Numbers

Kaival Brands (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has reported its Q1 numbers for the period ending Jan. 31, 2021; the report notes first-quarter revenues of $37 million and gross profit totals of $4.8 million. In addition, the company announced that it had achieved cumulative revenue of $100 million in less than a year and has reconfirmed its FY2021 revenue guidance of $400 to $450 million. These revenue milestones were the best to date for Kaival Brands, which is the exclusive global distributor of…

TuesdayMar 16, 2021 1:50 pm

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) (OTCQB: ISGIF) Unveils New Limited-Service Hospitality Liability Product

InsuraGuest Technologies (TSX.V: ISGI) (OTCQB: ISGIF), a leading U.S. insurance brokerage and consulting firm, has announced a new product: Limited-Service Hospitality Liability coverages. The product is offered through ISGI’s wholly owned U.S. subsidiary InsuraGuest RPG (“RPG”). The new product will be available to qualifying hotels, which are franchise limited-service hotels with less than 100 rooms and an average daily rate (“ADR”) under $100 a night. Of the 55,900-plus hotel properties in the United States, 33,000 are limited-service hotels, so the intended audience for the new service is impressive. ISGI’s property management system currently integrates with 82 different property management systems through…

TuesdayMar 16, 2021 1:39 pm

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Completes Enrollment in Upcoming Phase 2b Clinical Trial of Cystic Fibrosis Treatment

AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company specializing in the development of targeted, nonsystemic therapies for gastrointestinal (“GI”) diseases, has announced the completion of enrollment for its phase 2b OPTION 2 clinical trial to investigate MS1819 in cystic fibrosis (“CF”) patients with exocrine pancreatic insufficiency (“EPI”). According to the announcement, the company enrolled 30 CF patients for the study, which is anticipated to return top line data by the end of Q1 2021. The upcoming phase 2b, multicenter study will investigate the safety, tolerability and efficacy of MS1819 in a head-to-head comparison against the current porcine enzyme replacement therapy…

Site Search

Company Search

Category: QualityStocksNewsBreaks